HANNAH KING: Open Payments
NPI 1134897283 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 48 payments from 17 companies in 2025. Trend: 2023 $1,363 · 2024 $1,098 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $205 |
| Novo Nordisk Inc | 5 | $171 |
| Lilly USA, LLC | 9 | $147 |
| PFIZER INC. | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Astellas Pharma US Inc | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Exact Sciences Corporation | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
Products named: Wegovy, QULIPTA, MOUNJARO, UBRELVY, BREZTRI, NURTEC ODT, ZEPBOUND, Veozah.
Industry payments across IN — which companies pay providers there.
